WALTHAM, Mass.–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 30, 2012. “We executed well to deliver another strong quarter of revenue and earnings growth” Second Quarter Highlights • Adjusted earnings per share (EPS) grew 23% to a second quarter record […]
Cambridge, UK,: Horizon Discovery (Horizon), a leading provider of research tools to support the development of personalized medicines, today announced that it has signed a technology access agreement with the U.S. National Institutes of Health Center for Regenerative Medicine (NIH CRM), through Horizon’s Centers of Excellence (CoE) program. The agreement will enable the NIH CRM […]
CAMBRIDGE, Mass.– Today Firefly BioWorks announced the election of Victor R. Ambros, Ph.D. to the company’s Scientific Advisory Board. Dr. Ambros is the Silverman Professor of Natural Sciences in the Program in Molecular Medicine at the University of Massachusetts Medical School, and serves as co-director of the RNA Therapeutics Institute at UMass Medical. His laboratory […]
Hercules, CA and Austin, TX —— Bio Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, and Myriad RBM, Inc., a wholly owned subsidiary of Myriad Genetics Inc. (NASDAQ: MYGN), and a leading multiplex biomarker testing company, today announced that they have partnered to […]
Franklin Lakes, NJ – The Board of Directors of BD (Becton, Dickinson and Company) (NYSE:BDX) has declared a quarterly dividend of 45 cents per common share, payable on September 28, 2012 to holders of record on September 7, 2012. The indicated annual dividend rate is $1.80 per share. About BD BD is a leading global […]
HIGHLIGHTS: Q2 2012 Results (all percentages are to comparable periods in 2011) • Q2 2012 reported sales increased 4% to $664 million. Q2 2012 overall sales grew organically by 3% with Research and Sigma-Aldrich Fine Chemicals (“SAFC”) organic sales growth of 1% and 8%, respectively. Acquisitions contributed 6% to sales growth. Changes in foreign currency […]
SwitchGear Genomics Inc., a leading provider of products for studying the regulatory elements in the human genome, today announced the launch of a new service group for custom cloning and mutagenesis. These services will provide customers new ways to access the LightSwitch Luciferase Assay System™, a comprehensive reporter assay platform for studying transcriptional and post-transcriptional […]
Golden, Colorado —— Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced an expanded relationship with a key distributor of its stem cell-based products, privately-held Neuromics, Inc (www.neuromics.com). Vitro Biopharma officials recently met Neuromics principals at their corporate headquarters in Minneapolis, MN. Neuromics was formed in 2005 by Pete Shuster, a marketing and sales professional […]
GE Healthcare’s new illustra™ Ready-To-Go™ GenomiPhi™ kits provide researchers with a pre-dispensed, room temperature stable formulation for whole genome amplification, enabling a simplified workflow for obtaining large amounts of high quality DNA from small genomic DNA samples. The new kits also deliver improved yields over the current GenomiPhi kits. GE Healthcare is the leader in […]
FranklinLakes, NJ – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced that it has elected Rebecca W. Rimel to its Board of Directors, effective today. Ms. Rimel, 61, is President and Chief Executive Officer of The Pew Charitable Trusts, a public charity that applies a rigorous, analytical approach to improving […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
